Zerumin BCAS# 176050-49-0 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 176050-49-0 | SDF | Download SDF |
| PubChem ID | 16079165 | Appearance | Powder |
| Formula | C20H30O4 | M.Wt | 334.4 |
| Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 4-[(1R)-2-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-1-hydroxyethyl]-2-hydroxy-2H-furan-5-one | ||
| SMILES | CC1(CCCC2(C1CCC(=C)C2CC(C3=CC(OC3=O)O)O)C)C | ||
| Standard InChIKey | RWRUMHLQHKUMDS-YYVIIWQCSA-N | ||
| Standard InChI | InChI=1S/C20H30O4/c1-12-6-7-16-19(2,3)8-5-9-20(16,4)14(12)11-15(21)13-10-17(22)24-18(13)23/h10,14-17,21-22H,1,5-9,11H2,2-4H3/t14-,15+,16-,17?,20+/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Zerumin B Dilution Calculator
Zerumin B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.9904 mL | 14.9522 mL | 29.9043 mL | 59.8086 mL | 74.7608 mL |
| 5 mM | 0.5981 mL | 2.9904 mL | 5.9809 mL | 11.9617 mL | 14.9522 mL |
| 10 mM | 0.299 mL | 1.4952 mL | 2.9904 mL | 5.9809 mL | 7.4761 mL |
| 50 mM | 0.0598 mL | 0.299 mL | 0.5981 mL | 1.1962 mL | 1.4952 mL |
| 100 mM | 0.0299 mL | 0.1495 mL | 0.299 mL | 0.5981 mL | 0.7476 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Isoscutellarein 8-O-glucuronide
Catalog No.:BCX0451
CAS No.:56317-09-0
- (2E,4E)-6-Hydroxy-2,6-dimethylhepta-2,4-dienal
Catalog No.:BCX0450
CAS No.:220766-63-2
- 7,4'-Dihydroxyflavone 7-O-glucoside
Catalog No.:BCX0449
CAS No.:20633-86-7
- Zerumin
Catalog No.:BCX0448
CAS No.:180680-70-0
- 14-Deoxyisocoronarin D
Catalog No.:BCX0447
CAS No.:189239-51-8
- Morofficinaloside
Catalog No.:BCX0446
CAS No.:78964-45-1
- Durianol A
Catalog No.:BCX0445
CAS No.:1941203-91-3
- 1,7-Di-O-Galloyl-D-sedoheptulose
Catalog No.:BCX0444
CAS No.:126622-78-4
- 7-O-Galloyl-D-sedoheptulose
Catalog No.:BCX0443
CAS No.:233690-85-2
- Citrusin
Catalog No.:BCX0442
CAS No.:108943-57-3
- (12Z)-Labda-8(17),12-diene-14,15,16-triol
Catalog No.:BCX0441
CAS No.:1630864-26-4
- Thalifaramine
Catalog No.:BCX0440
CAS No.:105437-16-9
- 6'-O-Glucopyranosylpaeoniflorin
Catalog No.:BCX0453
CAS No.:1427054-21-4
- 21,23-Dihydro-21-hydroxy-23-oxonomilinic acid methyl ester
Catalog No.:BCX0454
CAS No.:2243600-34-0
- (-)-3-Hydroxy-p-menth-1-en-6-one
Catalog No.:BCX0455
CAS No.:78085-72-0
- Sanggenol G
Catalog No.:BCX0456
CAS No.:202526-52-1
- Sanggenon A
Catalog No.:BCX0457
CAS No.:76464-71-6
- Sanggenon M
Catalog No.:BCX0458
CAS No.:922080-11-0
- Breynioside A
Catalog No.:BCX0459
CAS No.:63555-02-2
- 6'-O-Glucopyranosylalbiflorin
Catalog No.:BCX0460
CAS No.:1001644-88-7
- (E)-14-Hydroxy-15-norlabda-8(17),12-dien-16-al
Catalog No.:BCX0461
CAS No.:114370-19-3
- Monardin C
Catalog No.:BCX0462
CAS No.:1262796-93-9
- 15-O-Ethylzerumin B
Catalog No.:BCX0463
CAS No.:1707019-00-8
- Alpinenone
Catalog No.:BCX0464
CAS No.:103425-23-6
Synthesis of (+)-zerumin B using a regioselective singlet oxygen furan oxidation.[Pubmed:18247492]
J Org Chem. 2008 Mar 7;73(5):2021-3.
A short and efficient synthesis of the antitumor diterpenoid (+)-Zerumin B has been accomplished starting from (+)-sclareolide. At the heart of the synthetic strategy lies the regioselective formation of the alpha-substituted gamma-hydroxybutenolide moiety of Zerumin B. This was achieved by means of a [1,4] O-->C triisopropylsilyl migration followed by singlet oxygen (1 O 2) oxidation of the resulting 2-triisopropylsilyl-3-(alpha-hydroxy)alkylfuran.
Synthesis and stereochemistry of the antitumor diterpenoid (+)-zerumin B.[Pubmed:16901169]
J Org Chem. 2006 Aug 18;71(17):6670-3.
Starting from commercially available (+)-sclareolide, the first synthesis of Zerumin B was achieved by a concise, highly efficient pathway featuring stereoselective addition of a new silyloxyfuryltitanium reagent to an aldehyde intermediate and silyloxyfuran oxyfunctionalization as key steps. The synthesis established the relative and absolute configuration of Zerumin B along with its identity with a purportedly new diterpenoid isolated from the plant Renealmia alpinia.
A labdane diterpene glucoside from the rhizomes of Curcuma mangga.[Pubmed:16038556]
J Nat Prod. 2005 Jul;68(7):1090-3.
A new labdane diterpene glucoside, curcumanggoside (1), together with nine known compounds, including labda-8(17),12-diene-15,16-dial (2), calcaratarin A (3), Zerumin B (4), scopoletin, demethoxycurcumin, bisdemethoxycurcumin, 1,7-bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one, curcumin, and p-hydroxycinnamic acid, have been isolated from the rhizomes of Curcuma mangga. Their structures were determined using a combination of 1D (1H NMR, 13C NMR, DEPT) and 2D (COSY, HSQC, HMBC) NMR techniques. All diarylheptanoids and scopoletin showed significant antioxidant activity. Zerumin B, demethoxycurcumin, bisdemethoxycurcumin, and curcumin also exhibited cytotoxic activity against a panel of five human tumor cell lines.
